Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (31-40 of 395) with videos related to

Pageof 40
Sort By:
Journal of Alzheimer'S Disease : JAD|September 4, 2023
Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic ReviewRoman Sattarov, Håkan Toresson, Camilla Orbjörn, et al.
Nature Communications|December 8, 2020
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Lakartidningen|June 11, 2013
[Niemann-Pick type C disease. Rare but possible diagnosis in adult neurology and psychiatry]Niklas Mattsson, Jan-Eric Månsson, Maria Blomqvist, et al.
Neuroscience Research|December 8, 2009
Converging molecular pathways in human neural development and degenerationNiklas Mattsson, Karin Sävman, Gustaf Osterlundh, et al.
Trends in Pharmacological Sciences|April 5, 2015
Amyloid biomarkers in Alzheimer's diseaseKaj Blennow, Niklas Mattsson, Michael Schöll, et al.
Current Pharmaceutical Design|July 7, 2011
Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatmentErik Portelius, Niklas Mattsson, Ulf Andreasson, et al.
JAMA Neurology|July 18, 2019
Staging β-Amyloid Pathology With Amyloid Positron Emission TomographyNiklas Mattsson, Sebastian Palmqvist, Erik Stomrud, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkNiklas Mattsson, Anders Lönneborg, Marina Boccardi, et al.
Current Opinion in Neurology|January 20, 2021
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's diseaseAntoine Leuzy, Nicholas C Cullen, Niklas Mattsson-Carlgren, et al.
Biomarkers in Medicine|April 9, 2011
Found in translation: a blood-based test for Niemann-Pick type C1Niklas Mattsson, Bob Olsson, Ulf Andreasson, et al.
Pageof 40

Showing results (31-40 of 395) with videos related to

Sort By:
Pageof 40
Journal of Alzheimer'S Disease : JAD|September 4, 2023
Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic ReviewRoman Sattarov, Håkan Toresson, Camilla Orbjörn, et al.
Nature Communications|December 8, 2020
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Lakartidningen|June 11, 2013
[Niemann-Pick type C disease. Rare but possible diagnosis in adult neurology and psychiatry]Niklas Mattsson, Jan-Eric Månsson, Maria Blomqvist, et al.
Neuroscience Research|December 8, 2009
Converging molecular pathways in human neural development and degenerationNiklas Mattsson, Karin Sävman, Gustaf Osterlundh, et al.
Trends in Pharmacological Sciences|April 5, 2015
Amyloid biomarkers in Alzheimer's diseaseKaj Blennow, Niklas Mattsson, Michael Schöll, et al.
Current Pharmaceutical Design|July 7, 2011
Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatmentErik Portelius, Niklas Mattsson, Ulf Andreasson, et al.
JAMA Neurology|July 18, 2019
Staging β-Amyloid Pathology With Amyloid Positron Emission TomographyNiklas Mattsson, Sebastian Palmqvist, Erik Stomrud, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkNiklas Mattsson, Anders Lönneborg, Marina Boccardi, et al.
Current Opinion in Neurology|January 20, 2021
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's diseaseAntoine Leuzy, Nicholas C Cullen, Niklas Mattsson-Carlgren, et al.
Biomarkers in Medicine|April 9, 2011
Found in translation: a blood-based test for Niemann-Pick type C1Niklas Mattsson, Bob Olsson, Ulf Andreasson, et al.
Pageof 40